InvestorsHub Logo
Followers 233
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Thursday, 06/27/2013 3:08:25 PM

Thursday, June 27, 2013 3:08:25 PM

Post# of 427816
On February 1, 2013 GlaxoSmithKline LLC submitted a sNDA under 505(b) for Lovaza.

They also submitted an amendment dated April 1, 2013.



http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_ApprovalHistory#apphist

It looks like Amarin and GSK intend to get married and have a Baby Lovaza 2, just EPA with possibly a NCE status.

Cool!

Bio
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News